Mark‐Specific Hazard Ratio Model with Multivariate Continuous Marks: An Application to Vaccine Efficacy (Q77966): Difference between revisions
From MaRDI portal
Created a new Item |
ReferenceBot (talk | contribs) Changed an Item |
||||||||||||||
(5 intermediate revisions by 5 users not shown) | |||||||||||||||
Property / publication date | |||||||||||||||
5 September 2013
| |||||||||||||||
Property / publication date: 5 September 2013 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / author | |||||||||||||||
Property / author: Michal Juraska / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / author | |||||||||||||||
Property / author: Peter B. Gilbert / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / title | |||||||||||||||
Mark‐Specific Hazard Ratio Model with Multivariate Continuous Marks: An Application to Vaccine Efficacy (English) | |||||||||||||||
Property / title: Mark‐Specific Hazard Ratio Model with Multivariate Continuous Marks: An Application to Vaccine Efficacy (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / zbMATH Open document ID | |||||||||||||||
Property / zbMATH Open document ID: 1274.62801 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / full work available at URL | |||||||||||||||
Property / full work available at URL: http://europepmc.org/articles/pmc3940058 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / Mathematics Subject Classification ID | |||||||||||||||
Property / Mathematics Subject Classification ID: 62P10 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / zbMATH DE Number | |||||||||||||||
Property / zbMATH DE Number: 6206059 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / zbMATH Keywords | |||||||||||||||
competing risks | |||||||||||||||
Property / zbMATH Keywords: competing risks / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / zbMATH Keywords | |||||||||||||||
Cox regression model | |||||||||||||||
Property / zbMATH Keywords: Cox regression model / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / zbMATH Keywords | |||||||||||||||
density ratio model | |||||||||||||||
Property / zbMATH Keywords: density ratio model / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / zbMATH Keywords | |||||||||||||||
failure time data | |||||||||||||||
Property / zbMATH Keywords: failure time data / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / zbMATH Keywords | |||||||||||||||
genetic data | |||||||||||||||
Property / zbMATH Keywords: genetic data / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / zbMATH Keywords | |||||||||||||||
mark variable | |||||||||||||||
Property / zbMATH Keywords: mark variable / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / zbMATH Keywords | |||||||||||||||
mark-specific vaccine efficacy | |||||||||||||||
Property / zbMATH Keywords: mark-specific vaccine efficacy / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / Wikidata QID | |||||||||||||||
Property / Wikidata QID: Q41991287 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / MaRDI profile type | |||||||||||||||
Property / MaRDI profile type: MaRDI publication profile / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / OpenAlex ID | |||||||||||||||
Property / OpenAlex ID: W1907075229 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / cites work | |||||||||||||||
Property / cites work: Large sample theory of maximum likelihood estimates in semiparametric biased sampling models. / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / cites work | |||||||||||||||
Property / cites work: Maximum likelihood estimation in semiparametric selection bias models with application to AIDS vaccine trials / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / cites work | |||||||||||||||
Property / cites work: The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacy / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / cites work | |||||||||||||||
Property / cites work: Proportional hazards tests and diagnostics based on weighted residuals / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / cites work | |||||||||||||||
Property / cites work: Nonparametric estimation of the joint distribution of survival time and mark variables / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / cites work | |||||||||||||||
Property / cites work: Improving the efficiency of the log-rank test using auxiliary covariates / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / cites work | |||||||||||||||
Property / cites work: The Analysis of Failure Times in the Presence of Competing Risks / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / cites work | |||||||||||||||
Property / cites work: Inferences for case-control and semiparametric two-sample density ratio models / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / cites work | |||||||||||||||
Property / cites work: A goodness-of-fit test for logistic regression models based on case-control data / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / cites work | |||||||||||||||
Property / cites work: A Bootstrap Revival of Some Nonparametric Distance Tests / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / cites work | |||||||||||||||
Property / cites work: An improved Bonferroni procedure for multiple tests of significance / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / cites work | |||||||||||||||
Property / cites work: Proportional hazards models with continuous marks / rank | |||||||||||||||
Normal rank | |||||||||||||||
links / mardi / name | links / mardi / name | ||||||||||||||
Latest revision as of 21:02, 6 July 2024
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Mark‐Specific Hazard Ratio Model with Multivariate Continuous Marks: An Application to Vaccine Efficacy |
scientific article |
Statements
69
0 references
2
0 references
328-337
0 references
19 February 2013
0 references
5 September 2013
0 references
Mark‐Specific Hazard Ratio Model with Multivariate Continuous Marks: An Application to Vaccine Efficacy (English)
0 references
competing risks
0 references
Cox regression model
0 references
density ratio model
0 references
failure time data
0 references
genetic data
0 references
mark variable
0 references
mark-specific vaccine efficacy
0 references
0 references
0 references
0 references